Clinical [2] and experimental [3] results indicate that diabetes is characterized by the up-regulation of both systemic and local angiotensin II (Ang II), and interventions targeting Ang II ameliorates the pathological changes of DCM. This evidence concerns the gene AGT and familial dilated cardiomyopathy.